Results 91 to 100 of about 2,306 (123)

Ecological Perspectives on Leishmaniasis Parasitism Patterns: Evidence of Possible Alternative Vectors for <i>Leishmania</i> (<i>Leishmania</i>) <i>infantum</i> (syn. <i>L. chagasi</i>) and <i>Leishmania</i> (<i>Viannia</i>) <i>braziliensis</i> in Piauí, Brazil. [PDF]

Pathogens
de Sousa RLT, Araujo-Pereira T, Vasconcelos SA, Freire SM, Lima OB, Dos Santos-Mallet JR, Vilela ML, Vasconcelos VMS, de Andrade EB, Gomes R, Teixeira C, Carvalho BM, Pita-Pereira D, Britto C.   +13 more
europepmc   +1 more source

Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis. [PDF]

Commun Biol
Zulfiqar B, Colombo FA, Nunes JB, Espuri PF, Ferreira AF, Manthri S, De Rycker M, Marques MJ, Avery VM.   +8 more
europepmc   +1 more source

The F1F3 recombinant chimera induced higher vaccine efficacy than its independent F1 and F3 components against <i>Leishmania</i> (<i>L.</i>) <i>infantum chagasi</i> mice infection. [PDF]

Front Immunol
Gomes DC, Fonseca-Ribeiro MP, Alves-Silva MV, Palatnik-de-Sousa CB.   +3 more
europepmc   +1 more source

Repurposing approved drugs targeting <i>Leishmania infantum</i> 5-Methylthioadenosine Phosphorylase as anti-leishmanial candidates. [PDF]

Front Cell Infect Microbiol
Abdelkrim YZ, Oualha R, Abbes S, Khalfaoui I, Mejri T, Barhoumi M, Abid H, Harigua-Souiai E, Guizani I.   +8 more
europepmc   +1 more source

Country-Level Canine Leishmaniosis Risk: A Literature Review, 2019-2023. [PDF]

Zoonoses Public Health
Swisher S, Tarrant S, Krus K, Chu F, Carroll A, Colvin T, Fowler JJ, MacGregor H, Onyewurunwa K, Taetzsch S, Abbott A, Straily A, Pieracci E.   +12 more
europepmc   +1 more source

Chromosome level genome assembly of the World Health standards Leishmania (Viannia) guyanensis M4147 and L. (V.) shawi M8408 using a hybrid sequencing approachFIRST REVIEW ROUND - REVIEWERS' COMMENTSREVIEWERS' COMMENTS. [PDF]

Mem Inst Oswaldo Cruz
Túllume-Vergara PO, de Lima ACS, Gomes CMC, Lima BS, Brandão-Filho SP, Silveira FT, Shaw JJ, Alves JMP.   +7 more
europepmc   +1 more source

Molecular diagnostics for cutaneous leishmaniasis: progress towards fulfilling the WHO target product profile. [PDF]

Parasitology
Jarzabek J, Denny PW.
europepmc   +1 more source

Risk factors for post-kala-azar dermal leishmaniasis (PKDL): Challenges in understanding pathophysiology. [PDF]

PLoS Negl Trop Dis
Zijlstra EE.
europepmc   +1 more source

Immunotherapy of Canine Leishmaniasis by Vaccination with Singlet Oxygen-Inactivated Leishmania infantum. [PDF]

Vaccines (Basel)
Manna L, Corso R, Kolli BK, Kim N, Chang KP.   +4 more
europepmc   +1 more source

Oxidative Stress and Survival of <i>Leishmania</i> spp.: A Relationship of Inverse Proportionality for Disease Outcome. [PDF]

Expert Rev Mol Med
Roy S, Mandal M, Halder M, Das PK, Ukil A.   +4 more
europepmc   +1 more source